Webinar: Preparing for M&A's

For many biotech and life sciences companies, an M&A process is a once-in-a-lifetime event that combines high stakes, tight timelines and significant complexity. Beyond the science and the valuation, a successful exit or investment round depends on a wide range of legal and organisational choices that are often underestimated until it is too late:

• How do you structure a data room which will help you mitigate risk during the transaction process?
• How do you negotiate favourable terms with your investment bank or M&A advisor?
• Should I opt for a broad auction process or a targeted market outreach to a handful of strategic/financial players?
• What is the role of the key stakeholders in the company (shareholders, board members, warrantholders, key clients and suppliers)?

These are exactly the questions that determine whether your M&A process will run smoothly or not. Getting them right requires preparation that starts long before the first term sheet lands on the table.

In this one hour session, Henri-Simon Vande Vyver, Senior Managing Associate at Deloitte Legal, will share practical, hands-on insights drawn from transactions in the Belgian life sciences scene, including key statistics and trends on the local M&A market, concrete do's and don'ts, and a legal roadmap to help life sciences companies prepare for and navigate an M&A process.

Whether you are actively considering a transaction or simply want to be deal-ready when the opportunity arises, this session will give you the practical tools and legal awareness to approach the process on your own terms.